(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
7 Moves toward a Sound and Dynamic Way of life - 23 Must-Change Settings for iPhone Clients: Safeguard Yourself !
- 3Astronauts' brains change shape and position after time in space, study finds
- 4Vote in favor of Your #1 sort of pie
- 5Paraplegic engineer becomes the first wheelchair user to blast into space
- Grasping the Elements of Medical caretaker Pay rates: Factors That Shape Your Pay
- 6 Novice Cameras for 2024: Ideal for New Picture takers
- Kissing is an ‘evolutionary conundrum.’ Scientists just mapped its unexpected origins
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- See the moon shine with Saturn in the southern sky after sunset Dec. 26
- Must-See Attractions in Washington, D.C.
- A decade after Brazil’s deadly dam collapse, Indigenous peoples demand justice on the eve of COP30
- See the metal guts of a satellite in this wild X-ray view | Space photo of the day for Dec. 4, 2025
- ChatGPT served as "suicide coach" in man's death, lawsuit alleges
